Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/110917
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJohnston, I.en
dc.contributor.authorTan, M.en
dc.contributor.authorCao, J.en
dc.contributor.authorMatsos, A.en
dc.contributor.authorForrest, D.en
dc.contributor.authorSi, E.en
dc.contributor.authorFardell, J.en
dc.contributor.authorHutchinson, M.en
dc.date.issued2017en
dc.identifier.citationBehavioural Brain Research, 2017; 334:109-118en
dc.identifier.issn0166-4328en
dc.identifier.issn1872-7549en
dc.identifier.urihttp://hdl.handle.net/2440/110917-
dc.description.abstractChemotherapy can cause serious neurotoxic side effects, such as painful peripheral neuropathies and disabling cognitive impairments. Four experiments examined whether Ibudilast, a clinically approved neuroimmune therapy, would reduce tactile allodynia and memory impairments caused by oxaliplatin in laboratory rats. Rats received an intraperitoneal injection of oxaliplatin (6mg/kg i.p.) or vehicle and were assessed for tactile allodynia 3 or 5days after injection, memory impairments in the novel object and novel location recognition tests 10-12days after injection, and fear conditioning 14days after injection. Ibudilast (7.5mg/kg) or vehicle was administered prior to oxaliplatin (Experiments 1 and 3) or prior to behavioural testing (Experiments 2 and 4). Ibudilast treatment prior to oxaliplatin prevented the development of tactile allodynia and memory impairments. Ibudilast treatment prior to behavioural testing reduced oxaliplatin-induced tactile allodynia, memory impairments, and impaired renewal of fear conditioning. These results suggest that Ibudilast could be an effective treatment against oxaliplatin-induced neuropathies and cognitive impairments.en
dc.description.statementofresponsibilityIan N. Johnstona, Manuela Tana, Jacob Caoa, Antigone Matsosa, Daniel R.L. Forresta, Emily Sia, Joanna E. Fardella, Mark R. Hutchinsoncen
dc.language.isoenen
dc.publisherElsevieren
dc.rights© 2017 Elsevier B.V. All rights reserved.en
dc.subjectOxaliplatin; chemotherapy; neuropathic pain; memory impairment; ibudilasten
dc.titleIbudilast reduces oxaliplatin-induced tactile allodynia and cognitive impairments in ratsen
dc.typeJournal articleen
dc.identifier.rmid0030074420en
dc.identifier.doi10.1016/j.bbr.2017.07.021en
dc.relation.granthttp://purl.org/au-research/grants/arc/DP110100297en
dc.identifier.pubid365712-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS10en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.